Rare-variant extensions of the transmission disequilibrium test: application to autism exome sequence data

American Journal of Human Genetics
Zongxiao HeSuzanne M Leal

Abstract

Many population-based rare-variant (RV) association tests, which aggregate variants across a region, have been developed to analyze sequence data. A drawback of analyzing population-based data is that it is difficult to adequately control for population substructure and admixture, and spurious associations can occur. For RVs, this problem can be substantial, because the spectrum of rare variation can differ greatly between populations. A solution is to analyze parent-child trio data, by using the transmission disequilibrium test (TDT), which is robust to population substructure and admixture. We extended the TDT to test for RV associations using four commonly used methods. We demonstrate that for all RV-TDT methods, using proper analysis strategies, type I error is well-controlled even when there are high levels of population substructure or admixture. For trio data, unlike for population-based data, RV allele-counting association methods will lead to inflated type I errors. However type I errors can be properly controlled by obtaining p values empirically through haplotype permutation. The power of the RV-TDT methods was evaluated and compared to the analysis of case-control data with a number of genetic and disease models. Th...Continue Reading

References

Jan 1, 1989·Genetic Epidemiology·J Ott
Dec 26, 2001·Trends in Endocrinology and Metabolism : TEM·Synthia H Mellon, Lisa D Griffin
Feb 9, 2005·American Journal of Human Genetics·Matthew Stephens, Paul Scheet
Feb 9, 2006·American Journal of Human Genetics·Jonathan MarchiniUNKNOWN International HapMap Consortium
Apr 19, 2006·Nature Reviews. Genetics·Nan M Laird, Christoph Lange
Jan 9, 2008·American Journal of Human Genetics·Ivan P GorlovChristopher I Amos
Jun 3, 2008·PLoS Genetics·Adam R BoykoCarlos D Bustamante
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Gregory V KryukovShamil R Sunyaev
Feb 14, 2009·PLoS Genetics·Bo Eskerod Madsen, Sharon R Browning
May 21, 2009·Human Molecular Genetics·Helena KilpinenLeena Peltonen
Oct 8, 2009·Genetic Epidemiology·Andrew P Morris, Eleftheria Zeggini
May 19, 2010·Nature Reviews. Genetics·Elizabeth T Cirulli, David B Goldstein
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Oct 27, 2010·PLoS Computational Biology·Gaurav BhatiaVineet Bafna
Dec 22, 2010·Journal of Atherosclerosis and Thrombosis·Nobukiyo TanakaShinji Yokoyama
Feb 25, 2011·Neuro-Signals·Javaneh Tamiji, Dorota A Crawford
Jun 2, 2011·Nature Reviews. Genetics·Jurg OttMark Lathrop
Sep 3, 2011·American Journal of Human Genetics·Dan-Yu Lin, Zheng-Zheng Tang
Nov 1, 2011·Nature Neuroscience·Matthew W State, Pat Levitt
Jul 19, 2012·Nature Reviews. Genetics·Joris A Veltman, Han G Brunner
Oct 16, 2012·Genome Research·Wei ChenGonçalo R Abecasis
Jan 22, 2013·American Journal of Epidemiology·Jinghua LiuDavid V Conti
Feb 7, 2013·European Journal of Human Genetics : EJHG·Iuliana Ionita-LazaXihong Lin
Apr 11, 2013·JAMA : the Journal of the American Medical Association·Christiane ReitzUNKNOWN Alzheimer Disease Genetics Consortium
Jun 13, 2013·Genetic Epidemiology·Paul L AuerSuzanne M Leal
Jul 31, 2013·Nature Genetics·Christie M BuchoveckyMonica J Justice

❮ Previous
Next ❯

Citations

Feb 13, 2016·BMC Genetics·Stephanie A Santorico, Audrey E Hendricks
Nov 13, 2015·Nature Protocols·Damian SmedleyPeter N Robinson
May 12, 2015·Nature Genetics·Niklas KrummEvan E Eichler
Apr 1, 2015·Nature Reviews. Genetics·Jurg OttSuzanne M Leal
Mar 6, 2015·Journal of Biosciences·Dang Thanh HaiLe Sy Vinh
Jul 6, 2014·American Journal of Human Genetics·Seunggeung LeeXihong Lin
Jun 13, 2016·Neurobiology of Aging·Celeste SassiJohn Hardy
May 26, 2016·Human Genetics·Jack A KosmickiBenjamin M Neale
Sep 27, 2016·American Journal of Human Genetics·Jae Hoon SulShamil Sunyaev
Jul 31, 2014·Bioinformatics·Sungkyoung ChoiSungho Won
May 11, 2016·PloS One·Alper UzunJames Padbury
Jan 5, 2019·Genetic Epidemiology·Julian HeckerChristoph Lange
Jan 22, 2019·Translational Psychiatry·Ashok PatowaryZoran Brkanac
Apr 23, 2015·European Journal of Human Genetics : EJHG·David Curtis
Nov 2, 2019·Molecular Psychiatry·Shiguo LiuJi-Song Guan
Aug 31, 2020·Genetic Epidemiology·Asuman S Turkmen, Shili Lin
Jul 14, 2017·Molecular Autism·Jamie ReillySanbing Shen
Aug 3, 2020·European Journal of Human Genetics : EJHG·Linhai ZhaoSuzanne M Leal
Jul 10, 2021·Investigative Ophthalmology & Visual Science·Claire L SimpsonDwight Stambolian
Jul 28, 2021·Nature Genetics·Amy B WilfertEvan E Eichler
Mar 14, 2019·Human Heredity·Hongyan FangLing Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.